Blood and brain scans to study Parkinson's disease progression
Treatments studied
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study looks at how a protein called alpha-synuclein spreads in Parkinson's disease by checking blood and brain scans. It aims to understand why some people develop Parkinson's and to find clues that could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 or older
- Have a Parkinson's disease diagnosis (or be a healthy control, or have REM sleep behavior disorder)
- For Parkinson's group: symptoms have lasted between 3 and 7 years
- Be able to walk independently or with minor help (Hoehn & Yahr stage 3 or less)
- No dementia, other neurological disorders, or significant infections, autoimmune diseases, or cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to look at the brain in people with REM sleep behavior disorder (RBD), a condition that can be an early sign of Parkinson's disease. By comparing them with healthy volunteers, researchers hope to find early markers of Parkinson's that could lead to earlier diagnosis and treatment.
This study examines brain changes in people with REM sleep behavior disorder (acting out dreams during sleep) and early Parkinson's disease using brain imaging scans. Researchers want to understand how sleep problems relate to Parkinson's development and find early warning signs.
This study uses brain scans to understand Parkinson's disease. It compares people with Parkinson's to healthy volunteers to learn how the brain changes.
This study looks at a genetic marker called LRRK2 that might help identify different types of Parkinson's. You'll have blood tests and an MRI scan to help researchers understand this. It could lead to better treatments and care.
This study collects blood and related samples to create a “biobank” and uses lab tests to study genetic risk in Parkinson’s disease and idiopathic REM sleep behavior disorder (RBD). It may help researchers understand why symptoms develop and improve future prevention or treatment approaches.
This study looks at early (before full disease) Parkinson-like symptoms in people who carry a specific genetic change called GBA1. It may help researchers understand who could develop Parkinson’s and how early signs can be tracked.
Hear when a new REM Sleep Behavior Disorder (iRBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.